Français Néerlandais Japonais Chinois Allemand Espagnol Portugais

Major innovation in fight against pleural cancer

05 Apr 2016 | Health Nutrition, A region on the move

Lille hospital plays a key role in new treatment for pleural cancer.

Healthcare innovation in Northern France

For over 10 years, medicine had made no progress in treating cancer of the pleura, the membrane lining the lungs.

But now the Bio-MAPS program, launched by Dr. Gérard Zalcman in close cooperation with 70 French hospital groups, has shown that Bevacizumab is effective in treating pleural cancer, significantly reducing mortality risk in 23% of patients who were treated with it.

Dr. Arnaud Scherpereel, head of pulmonology and thoracic oncology at Lille University Hospital Center (CHRU) and coordinator of the Bevacizumab project, stresses that the treatment is equally effective in all patient sub-groups, including those with the worst prognosis factors.

As a result, this new treatment solution is becoming the first-line therapy for patients with pleural cancer.

Back to news

News

E-Valley: Europe’s largest logistics project now under construction

E-Valley’s building permit has been signed, and Air Base 103 in Cambrai will soon be converted into an e-commerce logistics platform. Take a sneak peek inside the largest European smart hub, at the...

Liberty Aluminium Dunkerque: already €100M in planned investments

Shortly after the acquisition of Aluminium Dunkerque, Sanjeev Gupta announced an investment of €100 million over three years to modernize the smelter in Dunkirk, Hauts-de-France

All news